• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[三种化学发光法与放射免疫分析法在分化型甲状腺癌随访中甲状腺球蛋白测量的比较]

[Comparison of three chemiluminescent methods with a radioimmunoassay for thyroglobulin measurement in the follow-up of differentiated thyroid cancer].

作者信息

Sylla Niang M, Bombled C, Schlumberger M, Bidart J M

机构信息

Faculté de Médecine, Pharmacie et Odontologie, Département de Sciences biologiques et pharmaceutiques appliquées, Service d'Immunologie, Université Cheikh Anta DIOP de Dakar, Sénégal.

出版信息

Dakar Med. 2007;52(3):225-30.

PMID:19097407
Abstract

INTRODUCTION

Serum thyroglobulin measurements play an integral role in clinical evaluation of patients with thyroid cancer. Serum thyroglobulin is a highly specific and sensitive tumor marker for detecting persistent or recurrent thyroid cancer but also for monitoring clinical status. Actually, chemiluminescent methods gain ground on the radioimmunological methods because they offer the practical advantage of a shorter incubation time, a wider range of measured values and a reagent marked antibody more stable, less fragile than those used on radioimmunoassay. The aim of this study was to compare, by correlation study, three chemiluminescent methods to the reference radioimmunological method usually used in laboratories.

MATERIALS AND METHODS

Thyroglobulin was measured in 203 patients by the 3 following analyzers: Nichols Advantage (Nichols Institute Diagnostics, CA, USA), Immulite 2000 ( DPC Roche, Siemens, Los Angeles, USA) and Elecsys 2010 (Roche Diagnostics, Manheim, Germany); and by manual method (SELco Tg (Medipan Diagnostica, Berlin, Germany). Correlation analysis with OriginLab software version 7.0 was performed in order to compare thyroglobulin distribution values measured by the different methods.

RESULTS

Correlation coefficients obtained were for Medipan/ Immulite 2000: 0.95 (n = 80); for Medipan/Elecsys: 0.97 (n = 31); for Medipan/Advantage: r = 0.96 (n = 73).

CONCLUSIONS

Chemioluminescent technics we studied could be validly used in patients without anti-thyroglobulin antibody. The correlation coefficients we obtained allow us to select one of these automated methods after their performance was studied.

摘要

引言

血清甲状腺球蛋白检测在甲状腺癌患者的临床评估中起着不可或缺的作用。血清甲状腺球蛋白是检测持续性或复发性甲状腺癌以及监测临床状态的一种高度特异性和敏感性的肿瘤标志物。实际上,化学发光法正逐渐取代放射免疫法,因为它具有孵育时间短、测量值范围广以及标记抗体试剂更稳定、比放射免疫分析中使用的试剂更不易损坏等实际优势。本研究的目的是通过相关性研究,将三种化学发光法与实验室通常使用的参考放射免疫法进行比较。

材料与方法

采用以下三种分析仪对203例患者的甲状腺球蛋白进行检测:Nichols Advantage(美国加利福尼亚州Nichols研究所诊断公司)、Immulite 2000(美国洛杉矶DPC罗氏公司,西门子)和Elecsys 2010(德国曼海姆罗氏诊断公司);并采用手工方法(SELco Tg,德国柏林Medipan诊断公司)。使用OriginLab软件7.0版进行相关性分析,以比较不同方法测量的甲状腺球蛋白分布值。

结果

Medipan/Immulite 2000的相关系数为0.95(n = 80);Medipan/Elecsys的相关系数为0.97(n = 31);Medipan/Advantage的相关系数为r = 0.96(n = 73)。

结论

我们研究的化学发光技术可有效地用于无抗甲状腺球蛋白抗体的患者。我们获得的相关系数使我们能够在研究其性能后选择其中一种自动化方法。

相似文献

1
[Comparison of three chemiluminescent methods with a radioimmunoassay for thyroglobulin measurement in the follow-up of differentiated thyroid cancer].[三种化学发光法与放射免疫分析法在分化型甲状腺癌随访中甲状腺球蛋白测量的比较]
Dakar Med. 2007;52(3):225-30.
2
[Evaluation of an immunoassay for calcitonin].
Dakar Med. 2008;53(1):76-83.
3
Discordant serum thyroglobulin results generated by two classes of assay in patients with thyroid carcinoma: correlation with clinical outcome after 3 years of follow-up.两类检测方法在甲状腺癌患者中产生的血清甲状腺球蛋白结果不一致:与3年随访后的临床结局的相关性
Cancer. 2003 Jul 1;98(1):41-7. doi: 10.1002/cncr.11472.
4
[Standards, options and recommendations for blood tumor markers in thyroid cancers].[甲状腺癌血液肿瘤标志物的标准、选择及建议]
Bull Cancer. 2001 Aug;88(8):775-92.
5
Thyroglobulin: a specific serum marker for the management of thyroid carcinoma.甲状腺球蛋白:用于甲状腺癌管理的一种特异性血清标志物。
Clin Lab Med. 2004 Mar;24(1):29-47. doi: 10.1016/j.cll.2004.01.001.
6
Mutual interference between serum thyroglobulin and antithyroglobulin antibody in an automated chemiluminescent immunoassay.自动化学发光免疫分析中血清甲状腺球蛋白与抗甲状腺球蛋白抗体之间的相互干扰。
Clin Biochem. 2007 Jun;40(9-10):735-8. doi: 10.1016/j.clinbiochem.2007.03.010. Epub 2007 Mar 28.
7
The additive clinical value of combined thyroglobulin and antithyroglobulin antibody measurements to define persistent and recurrent disease in patients with differentiated thyroid cancer.联合检测甲状腺球蛋白和抗甲状腺球蛋白抗体对鉴别分化型甲状腺癌患者持续性疾病和复发性疾病的附加临床价值。
Nucl Med Commun. 2008 Oct;29(10):880-4. doi: 10.1097/MNM.0b013e328308e079.
8
Measuring thyroglobulin and thyroglobulin autoantibody in patients with differentiated thyroid cancer.检测分化型甲状腺癌患者的甲状腺球蛋白和甲状腺球蛋白自身抗体。
Nat Clin Pract Endocrinol Metab. 2008 Apr;4(4):223-33. doi: 10.1038/ncpendmet0757. Epub 2008 Feb 12.
9
Serum thyroglobulin measurement: clinical background and main methodological aspects with clinical impact.
Biomed Pharmacother. 2006 Sep;60(8):414-24. doi: 10.1016/j.biopha.2006.07.007. Epub 2006 Aug 17.
10
Recombinant human thyroid-stimulating hormone (Thyrogen) in thyroid cancer follow up: experience at a single institution.重组人促甲状腺激素(Thyrogen)在甲状腺癌随访中的应用:单机构经验
Intern Med J. 2009 Mar;39(3):156-63. doi: 10.1111/j.1445-5994.2008.01735.x.